Dyspareunia is persistent pain on attempted or successful vaginal penetration. It is under-reported, infrequently asked about by healthcare professionals, and affects quality of life and relationships. Dyspareunia is multifactorial and possesses biopsychosocial components. Pain may be distinct and localised, deep or persistent. Among the symptoms, women describe sensations of aching, throbbing and tearing. Disinterest in sex and relationship problems can result. This article discusses dyspareunia, its common differential diagnoses and aims to improve clinician confidence in assessing and managing dyspareunia in primary care.
Get full access to this article
View all access options for this article.
References
1.
BassonRAltofSDavisS, et al.(2004) Summary of the recommendations on sexual dysfunctions in women. The Journal of Sexual Medicine1(1): 24–34. DOI: 10.1111/j.1743-6109.2004.10105.x.
2.
BurrowsLJCreaseyAGoldsteinAT (2011) The treatment of vulvar lichen sclerosus and female sexual dysfunction. Journal of Sexual Medicine8(1): 219–222. DOI: 10.1111/j.1743-6109.2010.02077.x.
FaubionSKingsbergSShfrenJ, et al.(2020) The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society. Menopause: The Journal of The North American Menopause Society27(9): 976–992. DOI: 10.1097/GME.0000000000001609.
7.
FiferHSaundersJSunitaS, et al.(2020) UK national guideline for the management of infection with Neisseria Gonorrhoeae. International Journal of STD and AIDS3(1): 4–15. DOI: 10.1177/0956462419886775.
Hay P, Patel S and Daniels D (2012) UK national guideline for the management of Bacterial Vaginosis. Available at: www.bashhguidelines.org/media/1041/bv-2012.pdf (accessed 30 November 2020).
10.
KaoABinikYKapuscinskiA, et al.(2008) Dyspareunia in postmenopausal women: A critical review. Pain Research and Management13: 243–254. DOI: 10.1155/2008/269571.
11.
KrapfJMMitchellLHoltonM, et al.(2020) Vulvar lichen sclerosus: Current perspectives. International Journal of Womens Health15(12): 11–20. DOI: 10.2147/IJWH.S191200.
12.
terKuileMVanLangfeldJDeGrootE, et al.(2007) Cognitive-behavioral therapy for women with lifelong vaginismus: Process and prognostic factors. Behaviour Research and Therapy45(2): 359–373. DOI: 10.1016/j.brat.2006.03.013.
13.
LabrieFArcherDKoltunW, et al.(2016) Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause. Menopause23(3): 243–256. DOI: 10.1097/GME.0000000000000571.
14.
LavyYLev-SagieAHamaniY, et al.(2005) Modified vulvar vestibulectomy: Simple and effective surgery for the treatment of vulvar vestibulitis. European Journal of Obstetrics and Gynecology and Reproductive Biology120(1): 91–95. DOI: 10.1016/j.ejogrb.2004.04.039.
15.
LeeNJakesALloydJ, et al.(2018) Dyspareunia. BMJ (Online)361. DOI: 10.1136/bmj.k2341.
16.
LewisFMTatnallFVelangiS, et al.(2018) British Association of Dermatologists guidelines for the management of lichen sclerosus, 2018. British Journal of Dermatology178(4): 839–853. DOI: 10.1111/bjd.16241.
17.
LoteryHEGalaskRP (2003) Erosive lichen planus of the vulva and vagina. Obstetrics and Gynecology101: 1121–1125. DOI: 10.1016/S0029-7844(02)02383-9.
18.
MandalDNunnsDByrneM, et al.(2010) British Society for the Study of Vulval Diseases (BSSVD) guidelines for the management of vulvodynia. British Journal of Dermatology162(6): 1180–1185. Available at: https://doi.org/10.1111/j.1365-2133.2010.09684.x (accessed 29 December 2020).
19.
MitchellKGearyRGrahamC, et al.(2017) Painful sex (dyspareunia) in women: Prevalence and associated factors in a British population probability survey. BJOG: An International Journal of Obstetrics and Gynaecology124(11): 1689–1697. DOI: 10.1111/1471-0528.14518.
NwokoloNDragovicBPatelS, et al.(2015) UK national guideline for the management of infection with Chlamydia trachomatis. International Journal of STD and AIDS27(4): 251–267. DOI: 10.1177/0956462415615443.
SherrardJIsonCMoodyJ, et al.(2014) UK national guideline on the management of trichomonas vaginalis. International Journal of STD and AIDS25(8): 514–549. DOI: 10.1177/0956462414525947.
